Deep Medicine Acquisition Corp. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with TruGolf, Inc.
August 02, 2023 20:55 ET
|
Deep Medicine Acquisition Corp.
SALT LAKE CITY, Aug. 02, 2023 (GLOBE NEWSWIRE) -- – Deep Medicine Acquisition Corp. (NASDAQ: DMAQ) (“DMAQ” ), a publicly traded special purpose acquisition company, and TruGolf, Inc. ("TruGolf”), a...
TMT Acquisition Corp Announces the Separate Trading of its Ordinary Shares and Rights Commencing on May 1, 2023
April 27, 2023 13:35 ET
|
TMT Acquisition Corp
New York, NY, April 27, 2023 (GLOBE NEWSWIRE) -- TMT Acquisition Corp (the “Company”) (Nasdaq: TMTCU), a blank check company incorporated as a Cayman Islands exempted company formed for the purpose...
TMT Acquisition Corp Announces Pricing of $60 Million Initial Public Offering
March 27, 2023 19:27 ET
|
TMT Acquisition Corp
New York, New York, March 27, 2023 (GLOBE NEWSWIRE) -- TMT Acquisition Corp (the “Company”), a newly incorporated blank check company incorporated as a Cayman Islands exempted company formed for the...
Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO
March 22, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of...
Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO
March 20, 2023 08:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of...
Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO
March 17, 2023 08:10 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, March 17, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Measures regarding Excise Tax
February 01, 2023 17:43 ET
|
Aesther Healthcare Acquisition Corp.
NEW YORK and PROVIDENCE, R.I., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (SPAC) and Ocean Biomedical,...
Cetus Capital Acquisition Corp. Announces Pricing of $50,000,000 Initial Public Offering
January 31, 2023 16:39 ET
|
Cetus Capital Acquisition Corp.
DELAWARE, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Cetus Capital Acquisition Corp. (the "Company") announced today that it priced its initial public offering of 5,000,000 units at $10.00 per unit. The...
Homeland Security Corporation CEO Purchases of Company Stock
January 26, 2023 10:00 ET
|
Homeland Security Corporation
Carson City, Nevada, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Chief Executive Officer and President James Werner purchased a total of 665,028 unrestricted shares of Homeland Security Corporation...
SAGALIAM ACQUISITION CORP. CONFIRMS FUNDING AND EXTENSION OF DEADLINE TO COMPLETE INITIAL BUSINESS COMBINATION
January 23, 2023 06:20 ET
|
Sagaliam Acquisition Corp
New York, NY, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“we”, “us”, “our”, or the “Company”) announced today that it was exercising its option...